First in Man Trial - BIOSOLVE-I

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2014

Conditions
de Novo Lesions in Native Coronary Arteries
Interventions
DEVICE

AMS-3.0

Trial Locations (6)

Unknown

Middelheim Hospital, Antwerp

Universitätsklinik Essen, Westdeutsches Herzzentrum, Essen

Universitätsklinikum Freiburg, Freiburg im Breisgau

Lukaskrankenhaus Neuss, Neuss

Catharina Ziekenhuis, Eindhoven

Luzerner Kantonsspital, Lucerne

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biotronik AG

INDUSTRY